Non-Current Assets
Total Assets
Pfizer Total Assets decreased by 0.3% to $207.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $208.03B to $207.62B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 6.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Growth in total assets generally indicates business expansion, though it must be balanced against the debt used to finance those assets.
Detailed definition
Total assets represent the aggregate value of all current and non-current resources owned by the company. It serves as a...
Peer comparison
Used to compare the scale of operations between pharmaceutical peers.
Metric ID:
total_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $169.92B | $179.19B | $181.48B | $183.84B | $195.29B | $195.35B | $197.21B | $195.62B | $220.17B | $215.02B | $226.50B | $221.10B | $216.19B | $219.48B | $213.40B | $208.03B | $206.10B | $208.73B | $208.16B | $207.62B |
| QoQ Change | — | +5.5% | +1.3% | +1.3% | +6.2% | +0.0% | +0.9% | -0.8% | +12.6% | -2.3% | +5.3% | -2.4% | -2.2% | +1.5% | -2.8% | -2.5% | -0.9% | +1.3% | -0.3% | -0.3% |
| YoY Change | — | — | — | — | +14.9% | +9.0% | +8.7% | +6.4% | +12.7% | +10.1% | +14.9% | +13.0% | -1.8% | +2.1% | -5.8% | -5.9% | -4.7% | -4.9% | -2.5% | -0.2% |
Range$169.92B – $226.50B
CAGR+4.3%
Avg YoY Growth+4.1%
Median YoY Growth+4.2%
Current Streak2 quarters decline
Total Assets at Other Companies
Frequently Asked Questions
- What is Pfizer's total assets?
- Pfizer (PFE) reported total assets of $207.62B in Q1 2026.
- How has Pfizer's total assets changed year-over-year?
- Pfizer's total assets decreased by 0.2% year-over-year, from $208.03B to $207.62B.
- What is the long-term trend for Pfizer's total assets?
- Over 5 years (2020 to 2025), Pfizer's total assets has grown at a 6.2% compound annual growth rate (CAGR), from $154.23B to $208.16B.
- What does total assets mean?
- The sum of everything the company owns.